These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 12163111

  • 1. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs.
    Quelven I, Roussin A, Burlet-Schiltz O, Gouardères C, Tafani JA, Mazarguil H, Zajac JM.
    Eur J Pharmacol; 2002 Aug 02; 449(1-2):91-8. PubMed ID: 12163111
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the dorsal raphe nucleus.
    Dupouy V, Zajac JM.
    Eur J Pharmacol; 1997 Jul 09; 330(2-3):129-37. PubMed ID: 9253945
    [Abstract] [Full Text] [Related]

  • 3. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
    Gouardères C, Jhamandas K, Sutak M, Zajac JM.
    Br J Pharmacol; 1996 Feb 09; 117(3):493-501. PubMed ID: 8821539
    [Abstract] [Full Text] [Related]

  • 4. Spinal effect of a neuropeptide FF analogue on hyperalgesia and morphine-induced analgesia in mononeuropathic and diabetic rats.
    Courteix C, Coudoré-Civiale MA, Privat AM, Zajac JM, Eschalier A, Fialip J.
    Br J Pharmacol; 1999 Jul 09; 127(6):1454-62. PubMed ID: 10455296
    [Abstract] [Full Text] [Related]

  • 5. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs.
    Gouardères C, Sutak M, Zajac JM, Jhamandas K.
    Eur J Pharmacol; 2000 Oct 20; 406(3):391-401. PubMed ID: 11040346
    [Abstract] [Full Text] [Related]

  • 6. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A, Francés B, Roussin A, Latapie JP, Zajac JM.
    Brain Res; 1998 Oct 19; 808(2):166-73. PubMed ID: 9767158
    [Abstract] [Full Text] [Related]

  • 7. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
    Gouardères C, Roumy M, Advokat C, Jhamandas K, Zajac JM.
    Synapse; 2000 Jan 19; 35(1):45-52. PubMed ID: 10579807
    [Abstract] [Full Text] [Related]

  • 8. Cholera and pertussis toxins inhibit differently hypothermic and anti-opioid effects of neuropeptide FF.
    Francés B, Lahlou H, Zajac JM.
    Regul Pept; 2001 Apr 02; 98(1-2):13-8. PubMed ID: 11179773
    [Abstract] [Full Text] [Related]

  • 9. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis.
    Dupouy V, Zajac JM.
    Regul Pept; 1995 Nov 10; 59(3):349-56. PubMed ID: 8577940
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
    Fang Q, Wang YQ, He F, Guo J, Guo J, Chen Q, Wang R.
    Regul Pept; 2008 Apr 10; 147(1-3):45-51. PubMed ID: 18276024
    [Abstract] [Full Text] [Related]

  • 11. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q, Jiang TN, Li N, Han ZL, Wang R.
    Protein Pept Lett; 2011 Apr 10; 18(4):403-9. PubMed ID: 21121889
    [Abstract] [Full Text] [Related]

  • 12. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain.
    Desprat C, Zajac JM.
    Brain Res Dev Brain Res; 1994 Oct 14; 82(1-2):118-26. PubMed ID: 7842499
    [Abstract] [Full Text] [Related]

  • 13. Biochemical, cellular and pharmacological activities of a human neuropeptide FF-related peptide.
    Gelot A, Mazarguil H, Dupuy P, Francés B, Gouardères C, Roumy M, Zajac JM.
    Eur J Pharmacol; 1998 Aug 07; 354(2-3):167-72. PubMed ID: 9754917
    [Abstract] [Full Text] [Related]

  • 14. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice.
    Marchand S, Betourne A, Marty V, Daumas S, Halley H, Lassalle JM, Zajac JM, Frances B.
    Peptides; 2006 May 07; 27(5):964-72. PubMed ID: 16494968
    [Abstract] [Full Text] [Related]

  • 15. Functional consequences of neuropeptide FF receptors stimulation in mouse: a cerebral glucose uptake study.
    Quelven I, Roussin A, Zajac JM.
    Neuroscience; 2004 May 07; 126(2):441-9. PubMed ID: 15207362
    [Abstract] [Full Text] [Related]

  • 16. Neuropeptide FF, pain and analgesia.
    Roumy M, Zajac JM.
    Eur J Pharmacol; 1998 Mar 12; 345(1):1-11. PubMed ID: 9593588
    [Abstract] [Full Text] [Related]

  • 17. Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum.
    Takeuchi T, Fujita A, Roumy M, Zajac JM, Hata F.
    Jpn J Pharmacol; 2001 Aug 12; 86(4):417-22. PubMed ID: 11569615
    [Abstract] [Full Text] [Related]

  • 18. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
    Quelven I, Roussin A, Zajac JM.
    Eur J Pharmacol; 2005 Jan 31; 508(1-3):107-14. PubMed ID: 15680260
    [Abstract] [Full Text] [Related]

  • 19. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
    Pan JX, Wang ZL, Li N, Zhang N, Wang P, Tang HH, Zhang T, Yu HP, Zhang R, Zheng T, Fang Q, Wang R.
    Eur J Pharmacol; 2015 Nov 15; 767():119-25. PubMed ID: 26472125
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
    Kotlinska J, Pachuta A, Dylag T, Silberring J.
    Peptides; 2007 Nov 15; 28(11):2235-42. PubMed ID: 17884254
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.